Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin - PubMed (original) (raw)
Review
Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin
Boris Draznin. Diabetes. 2006 Aug.
Abstract
Initial attempts to unravel the molecular mechanism of insulin resistance have strongly suggested that a defect responsible for insulin resistance in the majority of patients lies at the postreceptor level of insulin signaling. Subsequent studies in insulin-resistant animal models and humans have consistently demonstrated a reduced strength of insulin signaling via the insulin receptor substrate (IRS)-1/phosphatidylinositol (PI) 3-kinase pathway, resulting in diminished glucose uptake and utilization in insulin target tissues. However, the nature of the triggering event(s) remains largely enigmatic. Two separate, but likely, complementary mechanisms have recently emerged as a potential explanation. First, it became apparent that serine phosphorylation of IRS proteins can reduce their ability to attract PI 3-kinase, thereby minimizing its activation. A number of serine kinases that phosphorylate serine residues of IRS-1 and weaken insulin signal transduction have been identified. Additionally, mitochondrial dysfunction has been suggested to trigger activation of several serine kinases, leading to a serine phosphorylation of IRS-1. Second, a distinct mechanism involving increased expression of p85alpha has also been found to play an important role in the pathogenesis of insulin resistance. Conceivably, a combination of both increased expression of p85alpha and increased serine phosphorylation of IRS-1 is needed to induce clinically apparent insulin resistance.
Similar articles
- Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites.
Delahaye L, Mothe-Satney I, Myers MG, White MF, Van Obberghen E. Delahaye L, et al. Endocrinology. 1998 Dec;139(12):4911-9. doi: 10.1210/endo.139.12.6379. Endocrinology. 1998. PMID: 9832428 - Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J. Gao Z, et al. Mol Endocrinol. 2004 Aug;18(8):2024-34. doi: 10.1210/me.2003-0383. Epub 2004 May 13. Mol Endocrinol. 2004. PMID: 15143153 - Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling.
Tanti JF, Gual P, Grémeaux T, Gonzalez T, Barrès R, Le Marchand-Brustel Y. Tanti JF, et al. Ann Endocrinol (Paris). 2004 Feb;65(1):43-8. doi: 10.1016/s0003-4266(04)95629-6. Ann Endocrinol (Paris). 2004. PMID: 15122091 Review. - Phosphorylation of IRS proteins, insulin action, and insulin resistance.
Boura-Halfon S, Zick Y. Boura-Halfon S, et al. Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E581-91. doi: 10.1152/ajpendo.90437.2008. Epub 2008 Aug 26. Am J Physiol Endocrinol Metab. 2009. PMID: 18728222 Review.
Cited by
- A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias.
Haroon J, Jordan K, Mahdavi K, Rindner E, Becerra S, Surya JR, Zielinski M, Venkatraman V, Goodenowe D, Hofmeister K, Zhang J, Ahlem C, Reading C, Palumbo J, Pourat B, Kuhn T, Jordan S. Haroon J, et al. Medicine (Baltimore). 2024 Jul 26;103(30):e39027. doi: 10.1097/MD.0000000000039027. Medicine (Baltimore). 2024. PMID: 39058809 Free PMC article. Clinical Trial. - Serum klotho as a novel biomarker for metabolic syndrome: findings from a large national cohort.
Yuguang L, Chang Y, Chen N, Zhao Y, Zhang X, Song W, Lu J, Liu X. Yuguang L, et al. Front Endocrinol (Lausanne). 2024 Mar 4;15:1295927. doi: 10.3389/fendo.2024.1295927. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38501099 Free PMC article. - The role of captopril in leukotriene deficient type 1 diabetic mice.
Guimarães JPT, Queiroz LAD, Menikdiwela KR, Pereira N, Ramalho T, Jancar S, Moustaid-Moussa N, Martins JO. Guimarães JPT, et al. Sci Rep. 2023 Dec 13;13(1):22105. doi: 10.1038/s41598-023-49449-8. Sci Rep. 2023. PMID: 38092813 Free PMC article. - Schisandrin A Alleviates Spatial Learning and Memory Impairment in Diabetic Rats by Inhibiting Inflammatory Response and Through Modulation of the PI3K/AKT Pathway.
Guo X, Lei M, Ma G, Ouyang C, Yang X, Liu C, Chen Q, Liu X. Guo X, et al. Mol Neurobiol. 2024 May;61(5):2514-2529. doi: 10.1007/s12035-023-03725-w. Epub 2023 Nov 1. Mol Neurobiol. 2024. PMID: 37910285 - Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome.
Widjaja NA, Caesar LA, Nova S, Ardianah E. Widjaja NA, et al. J Obes. 2023 Oct 3;2023:4574042. doi: 10.1155/2023/4574042. eCollection 2023. J Obes. 2023. PMID: 37822716 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous